Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 9, 2011, Pages 714-715

  Constantinescu, Radu ^a   Romer, Megan ^b   Zetterberg, Henrik ^c   Rosengren, Lars ^a   Kieburtz, Karl ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Biomarker; Cerebrospinal fluid; Huntington's disease; Neurodegenerative disorders; Tau protein

Indexed keywords

N (7 HYDROXY 2,2,4,6 TETRAMETHYL 1 INDANYL) 4 (3 METHOXYPHENYL) 1 PIPERAZINEACETAMIDE; TAU PROTEIN;

ADULT; CAG REPEAT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUNTINGTON CHOREA; LETTER; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; UNIFIED HUNTINGTON DISEASE RATING SCALE;

FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAU PROTEINS;

EID: 80054860997     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.010     Document Type: Letter

References (5)

1. Hesse C., Rosengren L., Andreasen N., Davidsson P., Vanderstichele H., Vanmechelen E., et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 2001 Jan 19, 297(3):187-190.
2. Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010 Mar, 6(3):131-144.
3. The Huntington Study Group Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. The Huntington Study Group. Neurology 1998 May, 50(5):1366-1373.
4. Constantinescu R., Romer M., Oakes D., Rosengren L., Kieburtz K. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease. Parkinsonism Relat Disord 2009 Mar, 15(3):245-248.
5. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol 1995 Dec, 26(3):231-245.